1.Mode of energy and metabolism which related to three state line systems of membrane-redoxy potentials and rlung, mkris, badgan symbolic coded
Narantsetseg B ; Narantsetseg J, Sarantsetseg B ; Khishigjargal S ; Ambaga M
Mongolian Medical Sciences 2013;166(4):57-62
Background. This study is to determine mode of metabolism on triple collaboration bridges of traditional medicine, modern medicine and NCM.Goal. To determine membrane redoxy potentials three line involves important regulation factors on mode of metabolism which relationship connected with rlung, mkris, and badgan symbolic code.Materials and Methods. Only 81 healthy individuals were involved in the study. Proton leak was determined by quantity rate of MDA in cell membrane and membrane resistance, proton conductance was determined by serum and urine oxidase activity.Results. The table 1 shows quantity rate of membrane resistance was decreased 1.08-1.52 fold, HDL content was decreased, and however LDL was increased. This result is to manifest low proton leak which means this type is likely belonged to badgan symbolic code with qualities cold fatty, earth, water. The table 2 shows serum and urine oxidize activity 2.22-6.1 fold was increased, HDL content was increased; UCP-3 gene activity relatively was increased. This result is to manifest highproton conductance which means this type is likely belonged to mkris symbolic code with qualities hot fatty, fire.Conclusions:1. Individuals with high proton leak and slow proton conductance had serum and urine oxidize activity were weak, therefore there are visceral and subcutaneous fat were low.2. Individuals with medium proton leak and high proton conductance had serum and urine oxidize activity were high, therefore there are visceral was low and subcutaneous fat was high.3. Individuals with weak proton leak and medium proton conductance had serum and urine oxidize activity were medium, therefore there are visceral was high and subcutaneous fat was low.
2. STUDY OF GLUCOSE-6-PHOSPATE DEHYDROGENASE IN HEALTH NEONATES
Khishigjargal B ; Gereltuya Y ; Gerelmaa N ; Tungalag L ; Gerelmaa Z ; Erdenetuya G
Innovation 2015;9(4):56-58
Glucose-6-phosphatase dehydrogenase (G6PD) deficiency is the most common enzyme deficiency in humans, affecting 400 million people worldwide and a high prevalence in persons of African, Middle Asian countries. The most common clinical manifestations are neonatal jaundice and acute hemolytic anemia, which is caused by the impairment of erythrocyte’s ability to remove harmful oxidative stress triggered by exogenous agents such as drugs, infection, or fava bean ingestion. Neonatal hyperbilirubinemia caused by glucose-6-phosphate dehydrogenase (G6PD) is strongly associated with mortality and long-term neurodevelopmental impairment. Aim:To determine a level of glucose-6-phosphate dehydrogenase in healthy neonates.The 76.5% of all participants (n=205) was assessed 4.36±1.15 Ug/Hb in normal reference range of G6PD other 23.5% (n=63) was 0.96±0.51 Ug/Hb with G6PD deficiency. In the both sex, 51.5% of male 0.88±0.46Ug/Hb (n=33) and 47.6%of female (n=30) 0.97±0.55Ug/Hb was assessed with G6PDdeficiency. Developing Jaundice period in number of 63 neonates with G6PD deficiency, 85.7% of neonates (n=54)was in 24-72 hours, 4% of neonates (n=3) was in 5-7 days and there is no sign of jaundice in 9% (n=6).Therefore neonates with G6PD deficiency, 53.9% (n=34)contiuned jaundice more than two weeks.G6PD deficiency was determined in male neonates (51.5%) more than female(47.6%). The 76.5% of all participants (n=205) was assessed 4.36±1.15 Ug/Hb in normal reference range of G6PD other 23.5% (n=63) of all participants was 0.96±0.51 Ug/Hb with G6PD deficiency. It shows that G6PD might be one potential risk of neonatal jaundice and hyperbilirubinemia in neonates in Mongolia.
3.Study of the Antischemin’s effect on immune response intensity
Oyuntsetseg S ; Ambaga M ; Sarantsetseg B ; Khishigjargal S
Mongolian Medical Sciences 2019;190(4):48-51
Background:
The immune response has become the basic use of today’s medical and biological sciences
understanding, definition and realization when first introduced into the cognitive level with new theory
of nine step closed cycle of protons related to membrane potentials three linear and s-NCM. Medicinal
preparations for the immune system derived from traditional herbs have rarely been used therefore,
we aim to determine the boost-reduction of immune response with preparation Antischemin with
ingredients of Gingko biloba, Astragalus membranaceus and Scutellaria baicalensis.
Materials and Methods:
This study was carried out on the innovation-research bio-modeling laboratory of the “New Medicine
Medical University”. Sheep blood was taken in heparin tube and centrifuged for 10min with speed
of 2000rpm and plasma was isolated. Blood components were washed with physiological solution
3-4 times and 10% blood red cell suspension was prepared. Prepared 0.2ml of 10% sheep red cell
suspension was injected to mice tail vein to create immune response model (N.K. Jerne and Nordin
(1963)). IL-4 (pg), antibody titre SRBC-IgM(ng/mL), and hemagglutinin titre (%) was measured
with ELISA kit and compared with control group. Comparing group animals used Salimon 1 ml/kg,
Dexamethasone 1 mg/kg orally. The study was conducted in accordance with the approval of Ethics
Review Committee of Ministry of Health (November 02, 2018 and approval number 10, №1).
Result :
In addition, comparing mice which used Antischemin 100 mg/kg orally with sheep blood injected
group at day 5, IL-4 level increased by 12.11%, but conclution of antibodies against sheep blood-IgM concentration decreased by 28.7%, and hemagglutinin titre decreased by 27.5%, meaning we
observed that the preparation can suppress immune response.
Сonclusions
Antischemin preparation meaning observed can suppress immune response.
4.Contribution of HBV and HCV infection in mortality of B cell non-Hodgkin’s lymphoma subjects
Myagmarjav B ; Anir E ; Delgerbat B ; Khishigjargal B ; Myadagsuren S ; Erdenetsogt D ; Dahgwahdorj Ya ; Davaadorj D ; Naranjargal D
Mongolian Medical Sciences 2020;191(1):19-25
Background:
The correlation between hepatitis B, C viruses (HBV, HCV) and B cell non-Hodgkin’s Lymphoma
(B-NHL) and reducing mortality have been studied extensively worldwide
Objective:
In this study, we aimed to determine the prevalence of HBsAg and anti-HCV positive cases among
B-NHL patients and its influence on the survival rate of these patients (on ≤12 months).
Materials and Methods:
We have done a retrospective analysis on patients who aged over 20 years and newly diagnosed at
the Hematology Center of the First State Hospital between 2015-2018. The patients’ information was
collected according the study ethics. We divided the patients into 2 groups, survival rate less than
12 months (≤12 months) and survival rate more than 13 months (≥13 months), and compared them
regarding age, gender, seroprevalence, and Ann-Arbor stage.
Results:
Overall, 226 patients (107 males and 119 females with average 54.4) were enrolled in the study.
There were 15% HBsAg positive and 41,6% anti-HCV positive cases, while Baatarkhuu et al. (2005)
reported (11.8%, 15.6%; p=0.160, p<0.00001) and Bekhbold et al. (2013) reported (11.1%, 10.6%;
p=0.055, p<0.00001) in apparently healthy population. Moreover, anti-HCV positive cases among
B-NHL patients were higher (p<0.00001) than those (27%) among hepatocellular carcinoma (HCC)
patients and same (p=0.404) with those (39%) among liver cirrhosis patients in Mongolia (Bolormaa
et al., 2009). Furthermore, 72.0% of all subjects in III-IV stages was accounted for HBsAg, anti-HCV
positive group which had ≤12 months, while 52.1% of them was accounted for HBsAg, anti-HCV
positive group which had ≥13 months and was statistical significantly lower (p=0.02).
Conclusion
Anti-HCV and HBsAg positive cases might contribute to survival rate with the B-NHL patients
diagnosed at the III-IV stages. HCV prevalence among B-NHL subjects was significantly higher than
that among the general population prevalence and was same with anti-HCV positive prevalence
among the HCC.
5.The results of acute exacerbation of chronic C hepatitis among Mongolian adults with B-Non-Hodgkin Lymphoma
Myagmarjav B ; Delgerbat B ; Khishigjargal B ; Myadagsuren S ; Oyundelger N ; Altankhuu M ; Erdenetsogt D ; Dahgwahdorj Ya ; Davaadorj D ; Naranjargal D
Mongolian Medical Sciences 2019;189(3):16-21
Background:
Chemotherapy-related acute exacerbation or hepatitis flares related to HCV positive B cell non-Hodgkin’s lymphoma (B-NHL) is one of the significant clinical issues
Material and Method:
We studied anti-HCV incidences among patients newly diagnosed with B-NHL, from 2015 to 2018. Survey data were collecting from medical history, electronic medical record system of First Central Hospital
was acquired and collected according to the research ethics (approved by Ethics Committee of Ministry
of Health, No.4 on June 19, 2017). Also, cases of chemotherapy-related acute exacerbation (AE) for
HCV-RNA positive cases were studied. Student’s t-test or nonparametric statistics were utilized to test
for statistically significant differences in continuous variables, whereas the chi-square or Fisher’s exact
test was used for categorical variables. p<0.05 was considered statistically significant.
Results:
The study showed that 39.5% of 233 cases with B-NHL are anti-HCV positive. Anti-HCV positive prevalence among B-NHL subjects was significantly higher compared to the general population. Chemotherapy-related AE occurred in 21.05% for the anti-HCV positive group and 36.36% for HCV-RNA positive group. Furthermore, before chemotherapy alanine aminotransferase (ALT) median was 15.2 for the group without AE, whereas it was 48.2 for the group with AE (p<0.01).
Conclusions
Our study showed that the prevalence of anti-HCV positive among B-NHL patients was significantly
higher than the general population prevalence. For all cases of AE, HCV-RNA was positive, and these
patients were treated with only chemotherapy without any anti-viral treatment. Anti-viral therapy needs to
be introduced urgently to prevent AE since liver fibrosis is aggravated quickly after AE.
6.Results of determination of salidroside content in roots and rhizomes of cultivated and natural Rhodiola rosea L
Khishigjargal B ; Lkhaasuren R ; Batdorj D ; Suvdaa T ; Gantogtokh G ; Orkhon N ; Tsetsegmaa S ; Khurelbaatar L
Mongolian Medical Sciences 2021;195(1):51-55
Introduction:
Rhodiola rosea L. (R.rosea) is a popular plant in traditional medicine of the Nordic countries, Eastern
Europe, and Asia. R.rosea plants are successfully cultivated in Mongolia. The Botanical Garden of
Medicinal Plants under the “Monos” Group started to cultivate R. rosea since May 2015.
Objective:
The aim of this research was to study the salidroside contents of R.rosea collected from Zavkhan
and Khuvsgul province, Mongolia, and cultivated in the Botanical Garden of Medicinal Plants, Drug
research Institute, Monos group.
Material and Methods:
The underground parts of wild roseroot plants were collected from April to May 2020 from Jargalant
soum, Khuvsgul province, and Nomrog soum, Zavkhan province, 3-years and 4-years-old cultivated
R.rosea gathered from the Botanical Garden of Medicinal Plants in April 2020. For comparison,
4-year-old Rhodiola grenulata (R. grenulata) was ordered from Shanxi Zhendong Genuine Medicinal
Materials Development Co., Ltd, China, and used for the study. The quantity of the salidroside
constituents of the underground parts were compared and the sourcing of roseroot raw material was
evaluated. Chemical analysis of roots and rhizome of R. Rosea namely the appearance, identification,
moisture, organic impurities, mineral impurities, residue on ignition, water-soluble extractives, fresh
weight of roots, and salidroside content were determined according to the National Pharmacopoeia of
Mongolia (NPhM) 2011. Microbiological analysis was performed in accordance with the requirements
of grade 3b specified in Annex 1 of the Order No. A / 219 of the Minister of Health dated May 30,
2017 to determine the degree of microbiological purity in medicinal products of roots and rhizome
raw materials.
Result:
The content of salidroside, the main biologically active substance of R.rosea plant, was 1.57% in
samples collected from Zavkhan province, 1.45% in samples collected from Khuvsgul province, 1.7%
in samples grown in China and 0.25% for 3-years-old samples and 1.89% for 4-years-old samples grown in the Botanical Garden of Medicinal Plants, Monos group, Mongolia. In addition, these raw
materials meet the general requirements for plant raw materials and microbiological parameters.
Conclusion
Samples of underground parts of R.rosea cultivated for 4 years in the Botanical Garden of Medicinal
Plants have the highest content (1.89%) of the salidrosde. Therefore, it is suggested that the roots
and rhizomes of R.rosea planted in the future can be standardized and used as a raw materials for
medicines.